Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Preventing Unnecessary Breast Biopsies Using MRI

By HospiMedica International staff writers
Posted on 30 Sep 2015
The results of a new study have shown that a new Magnetic Resonance (MR) breast imaging technique could prevent unnecessary biopsies.

The new technique, called Diffusion-Weighted Imaging with Background Suppression Magnetic Resonance Mammography (DWIBS-MRM), can be used to assess the diffusion of water molecules within tissue. More...
Diffusion could be restricted by malignant tumors for example. The results of the study were published in the online version of the journal Radiology.

DWIBS-MRM could be used to provide additional information for clinicians about suspicious findings discovered during X-Ray mammography screening. Conventional X-Ray mammography in itself can save lives, but often results in a high false-positive rate that leads to unnecessary biopsies.

DWIBS-MRM uses an abbreviated MR breast imaging protocol, and does not require the use of a contrast agent. The protocol shows the shape, and appearance of the lesion, and its biophysiological properties. A full breast MR protocol takes more than 30 minutes, while DWIBS-MRM images take less than 7 minutes, with a mean reading time of less than 30 seconds.

The study included 50 women with suspicious screening mammograms, and an indication for biopsy. The researchers compared a full diagnostic breast MR protocol, abbreviated contrast-enhanced MRI, and the new DWIBS-MRM technique. A breast carcinoma was found in 24 women.

The DWIBS-MRM technique was found to be as accurate as abbreviated contrast-enhanced and full diagnostic MRI protocols and resulted in a negative predictive value of 92%. However none of the MR techniques were able to detect pure microcalcification-related Ductal Carcinoma In-Situ (DCIS), without solid tumor.

Lead author of the study, Sebastian Bickelhaupt, MD, radiologist, German Cancer Research Center (Heidelberg, Germany), said, “If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-Ray mammography in breast cancer screening. This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”

Related Links:

Radiological Society of North America (RSNA)
German Cancer Research Center



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
External Defibrillator
HeartSave Y | YA
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.